FBN Bank (UK) Ltd:企業の戦略・SWOT・財務情報

◆英語タイトル:FBN Bank (UK) Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C8861
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,725見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥37,450見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥56,175見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

FBN Bank (UK) Ltd – Strategy, SWOT and Corporate Finance Report
Summary

FBN Bank (UK) Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

FBN Bank (UK) Ltd (FBNUK), a subsidiary of First Bank of Nigeria Ltd., offers commercial banking solutions to individuals and businesses in Europe and Africa. It offers saving accounts, term deposits, debit cards, working capital loans, current accounts, property funds, traditional funds and alternative funds, and notice accounts. The bank also offers services such as private banking, trust, custody and nominee, payment, cash letter clearing, trade finance, treasury, foreign exchange, and Internet banking. The bank also has a branch in Paris, and representative offices in Lagos and Abuja. FBNUK is headquartered in London, the UK.

Scope

- Detailed information on FBN Bank (UK) Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting FBN Bank (UK) Ltd in the form of a SWOT analysis
- An in-depth view of the business model of FBN Bank (UK) Ltd including a breakdown and examination of key business segments
- Intelligence on FBN Bank (UK) Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about FBN Bank (UK) Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of FBN Bank (UK) Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess FBN Bank (UK) Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on FBN Bank (UK) Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
FBN Bank (UK) Ltd: Company Overview 6
FBN Bank (UK) Ltd: Overview and Key Facts 6
FBN Bank (UK) Ltd: Overview 6
FBN Bank (UK) Ltd: Key Facts 6
FBN Bank (UK) Ltd: Key Employees 7
FBN Bank (UK) Ltd: Key Employee Biographies 9
FBN Bank (UK) Ltd: Major Products and Services 11
FBN Bank (UK) Ltd: Company History 12
FBN Bank (UK) Ltd: Management Statement 13
FBN Bank (UK) Ltd: Locations and Subsidiaries 16
FBN Bank (UK) Ltd: Key Competitors 17
FBN Bank (UK) Ltd: Company Analysis 18
FBN Bank (UK) Ltd: Business Description 18
FBN Bank (UK) Ltd: SWOT Analysis 19
FBN Bank (UK) Ltd: SWOT Overview 19
FBN Bank (UK) Ltd: Strengths 19
FBN Bank (UK) Ltd: Weaknesses 19
FBN Bank (UK) Ltd: Opportunities 20
FBN Bank (UK) Ltd: Threats 21
FBN Bank (UK) Ltd: Recent Developments 22
FBN Bank (UK) Ltd: News and Events Summary 22
FBN Bank (UK) Ltd: Business Expansion 22
FBN Bank (UK) Ltd: Financial Deals 22
FBN Bank (UK) Ltd: Strategy and Operations 23
Appendix 24
Contact Us 24
Methodology 24
About MarketLine 25

List of Tables
Table 1: FBN Bank (UK) Ltd: Key Facts
Table 2: FBN Bank (UK) Ltd: Key Employees
Table 3: FBN Bank (UK) Ltd: Company History
Table 4: FBN Bank (UK) Ltd: Locations and Subsidiaries
Table 5: FBN Bank (UK) Ltd: Key Competitors
Table 6: FBN Bank (UK) Ltd: News and Events Summary
Table 7: FBN Bank (UK) Ltd: Business Expansion
Table 8: FBN Bank (UK) Ltd: Financial Deals
Table 9: FBN Bank (UK) Ltd: Strategy and Operations



★海外企業調査レポート[FBN Bank (UK) Ltd:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Neurelis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neurelis Inc. (Neurelis) is a specialty pharmaceutical company, which develops medicines to target unmet medical need in epilepsy and acute anxiety episodes. The company's product portfolio includes NRL-1 (intranasal diazepam), a proprietary formulation, for epilepsy in pediatric and adult p …
  • Simcere Pharmaceutical Group-製薬・医療分野:企業M&A・提携分析
    Summary Simcere Pharmaceutical Group (Simcere) is a drug discovery company that manufactures and supplies branded generic and prescription pharmaceutical products. The company offers products in therapeutic areas including anti-tumor, central nervous, anti-infection, cardiovascular, skeletal muscle, …
  • Admiral Taverns Ltd.:企業の戦略・SWOT・財務情報
    Admiral Taverns Ltd. - Strategy, SWOT and Corporate Finance Report Summary Admiral Taverns Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Flex Ltd (FLEX)-医療機器分野:企業M&A・提携分析
    Summary Flex Ltd (Flex), formerly Flextronics International Ltd, is a provider of technology solutions. It designs, manufactures and provides supply chain services to original equipment manufacturers. The company’s major solutions include disposables, drug delivery, diagnostics devices, automotive e …
  • Nymox Pharmaceutical Corp (NYMX):企業の財務・戦略的SWOT分析
    Nymox Pharmaceutical Corp (NYMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Fletcher Building Ltd:企業の戦略・SWOT・財務情報
    Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report Summary Fletcher Building Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Louisville Gas and Electric Company:企業のM&A・提携動向(発電分野)
    Summary Louisville Gas and Electric Company (LG&E) a subsidiary of LG&E and KU Energy LLC is an electric and natural gas utility. The company provides gas storage and distribution services to residential and business customers. It has a total regulated generation capacity of 3,514 megawatts. The com …
  • PNE Wind AG:企業のM&A・提携・投資分析
    PNE Wind AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PNE Wind AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Novaliq GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops dermatological products, novel ophthalmic, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears a preserva …
  • Interleukin Genetics, Inc. (ILIU):企業のM&A・提携動向(医療機器分野)
    Summary Interleukin Genetics, Inc. (Interleukin) is a molecular diagnostics company. It develops and distributes genetic tests for the personalized health market. Its major genetic tests include PerioPredict genetic risk test; Weight management genetic test; Bone health genetic test; Heart health ge …
  • Aileron Therapeutics Inc:企業のM&A・提携動向(医療分野)
    Summary Aileron Therapeutics Inc (Aileron) is a clinical-stage biopharmaceutical company that develops and commercializes novel class of therapeutics. The company offers products such as stapled peptide drugs. Its stapled peptides penetrate cells throughout the body and modulate intracellular protei …
  • Domainex Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Domainex Ltd (Domainex) is a biotechnology company that provides drug discovery technologies and services. The company offers drug discovery services in the areas of medicinal chemistry, computational chemistry, protein expression and purification, biochemical assay development, DMPK analysi …
  • University of Texas Southwestern Medical Center:企業のM&A・提携動向(医療分野)
    Summary University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System, is an educational service provider that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, and other healthcare professionals. It offers degree progra …
  • NCsoft Corporation (036570):企業の財務・戦略的SWOT分析
    NCsoft Corporation (036570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Theranexus SAS (ALTHX):製薬・医療:M&Aディール及び事業提携情報
    Summary Theranexus SAS (Theranexus) is a biotechnology company that discovers and develops drug combinations for safe and efficient neurological and psychiatric treatments. The company develops THN102, a pipeline product that comprises modafinil. It also offers THN02 for the treatment of sleepiness …
  • Yunnan Salt & Chemical Co., Ltd. (002053):企業財務及び戦略的SWOT分析
    Summary Yunnan Salt & Chemical Co., Ltd. (YSCC), formerly Yunnan Salt Industry Corporation is a chemical company that manufactures and sells salt and salt chemical products. The company provides industrial salt, table salt, dry acid, caustic soda, and polyvinyl chloride. It also offers bath salts, f …
  • Lund University:製薬・医療:M&Aディール及び事業提携情報
    Summary Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The universi …
  • Bio-Modeling Systems SAS-製薬・医療分野:企業M&A・提携分析
    Summary Bio-Modeling Systems SAS (BM Systems) is a mechanism based medicine company which discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as Computer-Assisted Deductive Integration (CADI), which i …
  • Receptos, Inc. (formerly Receptor Pharmaceuticals, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Receptos, Inc. (formerly Recept …
  • The Co-Operators Group Limited:企業の戦略的SWOT分析
    The Co-Operators Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆